Changing TB Isolation Practices: New Guidelines for Molecular Testing

Dates: July 20, 2016

Training Format: 
Webinar

90-Minute Webinar

Originally aired July 20, 2016

This is the 1st of two webinars to highlight the NTCA/APHL Consensus Statement on the Use of Cepheid GeneXpert MTB/RIF Assay.  This training was presented by The National Tuberculosis Controllers Association (NTCA), the Association of Public Health Laboratories (APHL), the Southeastern National Tuberculosis Center (SNTC), and the Curry International Tuberculosis Center (CITC) .  

The training materials, including PDF handouts of the PowerPoint slides, are located here.

Presenters:

David Ashkin, MD, FCCP
Medical Director, SNTC
TB Control Section Division of Disease Control and Health Protection
Florida Department of Health

John Bernardo, MD

NTCA Co-Chair for Consensus Statement Workgroup
TB Medical Officer
Division of Global Populations and Infectious Disease Prevention
Massachusetts Department of Public Health

Dave Warshauer, PhD
APHL Co-Chair for Consensus Statement Workgroup
Deputy Director
Wisconsin State Laboratory of Hygiene
University of Wisconsin-Madison

Neha Shah, MD, MPH

Commander, US Public Health Service
Centers for Disease Control and Prevention
California Department of Public Health

 CME and CE units are not being offered for this recording and there is no participant evaluation.

Recording:

This training was recorded by Southeastern National Tuberculosis Center and the recording is available here: 

Changing TB Isolation Practices: New Guidelines for Molecular Testing